Advertisement

Orofacial Dystonias and Dyskinesias

  • Gary M. HeirEmail author
  • José L. de la Hoz
Chapter

Abstract

Oromandibular movement disorders have the potential to impair jaw function; affect orofacial expressions, facial appearance, and aesthetics; and impact on the quality of life of affected patients. A dentist trained in orofacial pain or oral medicine plays a primary role in the diagnosis and management of orofacial movement disorders. As dental awareness increases in the aging population, the importance of adequate knowledge of these clinical entities by the orofacial pain and oral medicine dental specialist becomes more important. The responsibility for recognition of movement disorders is also that of the general dentist as well, in order to provide appropriate treatment based on an accurate diagnosis. It must be kept in mind that due to the lack of methodologically sound studies supporting the various available therapeutic options, the importance of conservative and noninvasive restorative modalities for maintenance of an orofacial functional equilibrium is reinforced. This chapter will review the more common oromandibular movement disorders and treatments.

References

  1. 1.
    National Institute of Neurological Disorders and Stroke. http://www.ninds.nih.gov/disorders/dystonias/detail_dystonias.htm. 2016.
  2. 2.
    From Adams et al. Principles of neurology. 6th ed. McGraw Hill Medical: New York, Chicago, San Francisco. p. 108.Google Scholar
  3. 3.
  4. 4.
    Carlson N. Physiology of behavior. 6th ed. Needham Heights: Allyn and Bacon; 1998.Google Scholar
  5. 5.
  6. 6.
    Lavigne GJ, Khoury S, Abe S, Yamaguchi T, Raphael K. Bruxism physiology and pathology: an overview for clinicians. J Oral Rehabil. 2008;35:476–94.CrossRefPubMedGoogle Scholar
  7. 7.
    Goulet JP, Lund JP, Montplaisir JY. Daily clenching, nocturnal bruxism and their association with TMD symptoms [abstract]. J Orofac Pain. 1996;10:120.Google Scholar
  8. 8.
    Lavigne GJ, Montplaisir JY. Restless legs syndrome and sleep bruxism: prevalence and association among Canadians. Sleep. 1994;17:739–43.PubMedGoogle Scholar
  9. 9.
    Hublin C, Kaprio J, Partinen M, Koskenvuo M. Sleep bruxism based on self-report in a nationwide twin cohort. J Sleep Res. 1998;7:61–7.CrossRefPubMedGoogle Scholar
  10. 10.
    Okeson JP, Phillips BA, Berry DT, Cook Y, Paesani D, Galante J. Nocturnal bruxing events in healthy geriatric subjects. J Oral Rehabil. 1990;17:411–8.CrossRefPubMedGoogle Scholar
  11. 11.
    Manfredini D, Winocur E, Guarda-Nardini L, Paesani D, Lobbezoo F. Epidemiology of bruxism in adults: a systematic review of the literature. J Orofac Pain. 2013;27:99–1110.CrossRefPubMedGoogle Scholar
  12. 12.
    Nutt JG, Muenter MD, Aronson A, et al. Epidemiology of focal and generalized dystonia in Rochester, Minnesota. Mov Disord. 1988;3(3):188–94.CrossRefPubMedGoogle Scholar
  13. 13.
    Brin MF, Comella C, Jankovic J. Dystonia: “etiology, clinical features, and treatment”. Philadelphia: Lippincott Williams & Wilkins; 2004.Google Scholar
  14. 14.
    Blowers AJ, Borison RL, Blowers CM, et al. Abnormal involuntary movements in the elderly. Br J Psychiatry. 1981;139:363–4.PubMedGoogle Scholar
  15. 15.
    Kane JM, Woerner M, Lieberman J. Tardive dyskinesia: prevalence, incidence, and risk factors. J Clin Psychopharmacol. 1988;8(Suppl 4):52S–6S.PubMedGoogle Scholar
  16. 16.
    Cardoso F, Jankovic J. Dystonia and dyskinesia. Psychiatr Clin North Am. 1997;20(4):821–38.CrossRefPubMedGoogle Scholar
  17. 17.
    Richter A, Loscher W. Pathology of idiopathic dystonia: findings from genetic animal models. Prog Neurobiol. 1998;54(6):633–77.CrossRefPubMedGoogle Scholar
  18. 18.
    Abdo WF, et al. The clinical approach to movement disorders. Nat Rev Neurol. 2010;6:29–37. doi: 10.1038/nrneurol.2009.196.CrossRefPubMedGoogle Scholar
  19. 19.
    Thomas GA. Abnormal movements in the orofacial region. Diagnosis, assessment and control. A guide for the dental clinician. Aust Prothodont J. 1988;2:41–4.Google Scholar
  20. 20.
    Glark GT. Four oral motor disorders: bruxism, dystonia, dyskinesia and drug-induced dystonic extrapyramidal reactions. Dental Clinics Of North America [Dent Clin North Am] 2007;51(1):225-43, viii-ix.Google Scholar
  21. 21.
    Lobbezzoo F, et al. Bruxism defined and graded: an international consensus. J Oral Rehabil. 2012; doi: 10.1111/joor.12011.Google Scholar
  22. 22.
    De-La-HozAizpurua JL, Díaz-Alonso E, LaTouche-Arbizu R, Mesa-Jiménez J. Sleep bruxism. Conceptual review and update. Med Oral Patol Oral Cir Bucal. 2011;16(2):e231–8.CrossRefGoogle Scholar
  23. 23.
    Klasser GD, Rei N, Lavigne G. Sleep bruxism etiology: the evolution of a changing paradigm. J Can Dent Assoc. 2015;81:f2.PubMedGoogle Scholar
  24. 24.
    Lavigne GL, Huynh N, Kato T, Okura K, Adachi K, Yao D, Sessle B. Genesis of sleep bruxism: motor and autonomic-cardiac interactions. Arch Oral Biol. 2007;52(4):381–4.CrossRefPubMedGoogle Scholar
  25. 25.
    Schiffman E, Ohrbach R, Truelove E, Look J, Anderson G, Goulet JP, List T, Svensson P, Gonzalez Y, Lobbezoo F, Michelotti A, Brooks SL, Ceusters W, Drangsholt M, Ettlin D, Gaul C, Goldberg LJ, Haythornthwaite JA, Hollender L, Jensen R, John MT, De Laat A, de Leeuw R, Maixner W, van der Meulen M, Murray GM, Nixdorf DR, Palla S, Petersson A, Pionchon P, et al. Diagnostic criteria for temporomandibular disorders (DC/TMD) for clinical and research applications: recommendations of the international RDC/TMD consortium network* and orofacial pain special interest groupdagger. J Oral Facial Pain Headache. 2014;28:6–27J.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Benoliel R, Svensson P, Heir GM, Sirois D, Zakrzewska J, Oke-Nwosu J, Torres SR, Greenberg M, Klasser G, Katz J, Eliav E. Persistent orofacial muscle pain. Oral Dis. 2011;17(Suppl 1):23–41.CrossRefPubMedGoogle Scholar
  27. 27.
    Huynh NT, Rompré PH, Montplaisir JY, Manzini C, Okura K, Lavigne GJ. Comparison of various treatments for sleep bruxism using determinants of number needed to treat and effect size. Int J Prosthodont. 2006;19:435–41.PubMedGoogle Scholar
  28. 28.
    American Academy of Sleep Medicine. In: International Classification of Sleep Disorders, 3rd ed. Darien: IL American Academy of Sleep Medicine; 2014.Google Scholar
  29. 29.
    Sleep related bruxism. In: International classification of sleep disorders: diagnosis and coding manual. 2nd ed. Westchester: American Academy of Sleep Medicine; 2005. p. 189–92.Google Scholar
  30. 30.
    Lavigne GJ, Manzini C, Kato T. Sleep bruxism. In: Kryger MH, Roth T, Dement WC, editors. Principles and practice of sleep medicine. Philadelphia: Elsevier; 2005. p. 946–59.CrossRefGoogle Scholar
  31. 31.
    Long H, Liao Z, Wang Y, Liao L, Lai W. Efficacy of botulinum toxins in bruxism: an evidence-based review. Int Dent J. 2012;62:1–5.CrossRefPubMedGoogle Scholar
  32. 32.
    Balasubramaniam R, Saravanan R. Orofacial movement disorders. Oral Maxillofac Surg Clin North Am. 2008;20:273–85.CrossRefPubMedGoogle Scholar
  33. 33.
    Tolosa E, Marti MJ. Blepharospasm-oromandibular dystonia syndrome (Meige’s syndrome): clinical aspects. Adv Neurol. 1988;49:73–84.PubMedGoogle Scholar
  34. 34.
    Lee KH. Oromandibular dystonia. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2007;104(4):491–6.CrossRefPubMedGoogle Scholar
  35. 35.
    Sankhla C, Lai EC, Jankovic J. Peripherally induced oromandibular dystonia. J Neurol Neurosurg Psychiatry. 1998;65(5):722–8.CrossRefPubMedPubMedCentralGoogle Scholar
  36. 36.
    Lo SE, Gelb M, Frucht SJ. Geste antagonistes in idiopathic lower cranial dystonia. Mov Disord. 2007;22:7.Google Scholar
  37. 37.
    Verma SP, Sinha UK. Use of an intraoral sensory feedback device in the management of jaw opening dystonia. Otolaryngol Head Neck Surg. 2009;141:142–3.CrossRefPubMedGoogle Scholar
  38. 38.
    Assael LA. Maxillofacial movement disorders. Quintessence Pub: Hanover Park; 2006.Google Scholar
  39. 39.
    Blanchet PJ, Abdillahi O, Beauvais C, et al. Prevalence of spontaneous oral dyskinesia in the elderly: a reappraisal. Mov Disord. 2004;19(8):892–6.CrossRefPubMedGoogle Scholar
  40. 40.
    Jankovic J. Tardive syndromes and other drug-induced movement disorders. Clin Neuropharmacol. 1995;18(3):197–214.CrossRefPubMedGoogle Scholar
  41. 41.
    Steen VM, Lovlie R, MacEwan T, McCreadie RG. Dopamine D3-receptor gene variant and susceptibility to tardive dyskinesia in schizophrenic patients. Mol Psychiatry. 1997;2(2):139–45.CrossRefPubMedGoogle Scholar
  42. 42.
    Lohr JB. Oxygen radicals and neuropsychiatric illness – some speculatins. Arch Gen Psychiatry. 1991;48(12):1097–106.CrossRefPubMedGoogle Scholar
  43. 43.
    Scutcher HD, et al. Orofacial diskinesia: a dental dimension. JAMA. 1971;216(9):1459–63.CrossRefGoogle Scholar
  44. 44.
    Koller WC. Edentulous orodyskinesia. Ann Neurol. 1983;13:97–9; Ghika J, et al. Sensory symptoms in cranial dystonia: a potential role in the etiology? J Neurol Sci. 1993;116:142–47.Google Scholar
  45. 45.
    Blanchet PJ, Rompré PH, Lavigne GJ, Lamarche C. Oral dyskinesia: a clinical overview. Int J Prosthodont. 2005;18(1):10–9.PubMedGoogle Scholar
  46. 46.
    Girard P, Monette C, Normandeau L, et al. Contribution of orodental status to the intensity of orofacial tardive dyskinesia: an interdisciplinary and video-based assessment. J Psychiatr Res. 2012;46(5):684–7.CrossRefPubMedGoogle Scholar
  47. 47.
    Casey DE. The differential diagnosis of tardive dyskinesia. Acta Psychiatr Scand Suppl. 1981;291:71–87.CrossRefPubMedGoogle Scholar
  48. 48.
    Cummings JL, Wirshing WC. Recognition and differential diagnosis of tardive dyskinesia. Int J Psychiatry Med. 1990;19(2):133–44.CrossRefGoogle Scholar
  49. 49.
    Cloud LJ, Jinnah H. Treatment strategies for dystonia. Expert Opin Pharmacother. 2010;11(1):5–15. doi: 10.1517/14656560903426171.CrossRefPubMedPubMedCentralGoogle Scholar
  50. 50.
    Jabbari B, Paul J, Scherokman B, van Dam B. Posttraumatic segmental axial dystonia, movement disorders, published online: 12 Oct 2004.Google Scholar
  51. 51.
    Greene P, Shale H, Fahn S. Analysis of open-label trials in torsion dystonia using high dosages of anticholinergics and other drugs. Mov Disord. 1988;3(1):46–60. [PubMed: 3050472].CrossRefPubMedGoogle Scholar
  52. 52.
    Hughes AJ, Lees AJ, Marsden CD. Paroxysmal dystonic head tremor. Mov Disord. 1991;6(1):85–6. [PubMed: 2005930].CrossRefPubMedGoogle Scholar
  53. 53.
    Davis TL, Charles PD, Burns RS. Clonazepam-sensitive intermittent dystonic tremor. South Med J. 1995;88(10):1069–71. [PubMed: 7481966].CrossRefPubMedGoogle Scholar
  54. 54.
    Jankovic J, Ford J. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol. 1983;13(4):402–11. [PubMed: 6838174].CrossRefPubMedGoogle Scholar
  55. 55.
    Jinnah HA, Hess EJ. Experimental therapeutics for dystonia. Neurotherapeutics. 2008;5:198–209.CrossRefPubMedPubMedCentralGoogle Scholar
  56. 56.
    Greene P, Shale H, Fahn S. Experience with high dosages of anticholinergic and other drugs in the treatment of torsion dystonia. Adv Neurol. 1988;50:547–56.PubMedGoogle Scholar
  57. 57.
    Arce CA. Selective denervation in cervical dystonia. In: Stacey MA, editor. Handbook of dystonia. New York: Informa Healthcare USA; 2007. p. 381–92.Google Scholar
  58. 58.
    Krauss JK. Deep brain stimulation for dystonia in adults. Overview and developments Stereotact Funct Neurosurg. 2002;78(3–4):168–82.PubMedGoogle Scholar
  59. 59.
    Lobbezoo F, Hamburger HL, Naeije M. Movement disorders in the dental office. In: Paesani DA, editor. Bruxism, theory and practice. London: Quintessence Publishing Co. Ltd.; 2010. p. 99–109.Google Scholar
  60. 60.
    Schuter HD, et al. Facial movement disorders: a progress report. Quintessence Int. 1979;10:109–12.Google Scholar
  61. 61.
    Mack PJ. Two part record blocks: a clinical report. J Dent. 1980;8:182–3.CrossRefPubMedGoogle Scholar
  62. 62.
    Watanabe I, et al. Oral dyskinesia in the aged. II: EMG appearance and dental treatment. Gerodontics. 1988;4:310–4.PubMedGoogle Scholar

Suggested Reading

  1. Oliveira D, Jorge R, Daldas I, Carvalho F, Magalhaes T. Bruxism after 3,4-methylenedioxymethamphetamine (ecstasy) abuse. Clin Toxicol. 2010;48(8):863–4. 2p. 2.CrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.Center for Temporomandibular Disorders and Orofacial PainRutgers School of Dental MedicineNewarkUSA
  2. 2.Master Program in Temporomandibular Disorders & Orofacial Pain, School of MedicineCEU San Pablo UniversityMadridSpain

Personalised recommendations